April 4, 2024- Sysmex America, Inc. announces its plan to sell hemostasis instruments and reagents to laboratories in the United States beginning in April, under the company’s mutual OEM agreement with Siemens Healthineers.
With regulatory activities complete, the OEM agreement allows each company to distribute hemostasis instruments (provided by Sysmex) and reagents (provided by Siemens) under their respective brands. Both companies will market their hemostasis products and services independently of each other.